Search results
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 3 days agoA Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result ...
New Pathways for Treating Never-Smoker Lung Cancer | Newswise
Newswise· 3 days agoKorean joint research team have elucidated the overexpression of estrogen signaling pathways in specific Korean never-smoking lung cancer cases using multi
Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus...
Benzinga via Yahoo Finance· 6 days agoThursday, Summit Therapeutics Inc (NASDAQ:SMMT) announced that Phase 3 HARMONi-2, or AK112-303, met...
EMA CHMP recommends AstraZeneca’s Tagrisso for lung cancer
Pharmaceutical Technology via Yahoo Finance· 2 days agoUse (CHMP) of the European Medicines Agency (EMA) has recommended approving AstraZeneca's Tagrisso,...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 4 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters· 6 days ago, opens new tab Trodelvy failed to improve survival for patients with advanced bladder cancer and...
Hypoxemia due to sleep apnea is associated with risk of lung cancer reoccurrence
Medical Xpress· 2 days agoResults show that a 4% oxygen desaturation index of more than 15 and time spent in desaturation...
Pfizer says its its lung cancer drug Lorbrena could be a $1 billion blockbuster
Quartz· 6 days agoPharma giant Pfizer said that its lung cancer drug Lorbrena could reach blockbuster status by 2030...
...PFL-002/VERT-002, a Potential Treatment for Patients with Solid Tumors, Including Non-Small Cell ...
KETK· 1 day agoFood and Drug Administration ("FDA") to initiate a first-in-human (FIH) Phase I/II clinical trial with PFL-002/VERT-002 for solid tumors including non-small cell lung < ...
Bristol’s $250,000 Pill Slows Lung Cancer Growth by Seven Weeks
Bloomberg· 5 days agoHave a confidential tip for our reporters? A Bristol Myers Squibb Co. lung cancer treatment delayed...